Diagnostic Imaging Devices - Switzerland

The projected revenue for the Diagnostic Imaging Devices market market in Switzerland is estimated to reach US$533.20m by 2024.
This market is expected to demonstrate an annual growth rate of 4.25% (CAGR 2024-2029), leading to a market volume of US$656.60m by 2029.
In comparison to other countries worldwide, the United States is predicted to generate the highest revenue, amounting to US$11.93bn in 2024.
Switzerland's advanced healthcare system and strong focus on innovation have positioned it as a leading market for diagnostic imaging devices in the medical technology industry.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in Switzerland is experiencing steady growth and development due to various factors.

Customer preferences: Swiss customers in the Diagnostic Imaging Devices market have shown a strong preference for advanced and innovative imaging technologies. They value accuracy, efficiency, and safety in diagnostic procedures, and are willing to invest in cutting-edge imaging devices that can provide precise and detailed results. Swiss healthcare providers also prioritize patient comfort and convenience, leading to a demand for imaging devices that offer a seamless and comfortable experience for patients.

Trends in the market: One of the key trends in the Diagnostic Imaging Devices market in Switzerland is the increasing adoption of digital imaging technologies. Digital imaging offers numerous advantages over traditional film-based imaging, such as faster image acquisition, enhanced image quality, and easier storage and sharing of images. Swiss healthcare facilities are investing in digital imaging devices to improve workflow efficiency and enhance diagnostic capabilities. Another trend in the market is the rising demand for portable and handheld imaging devices. These compact and lightweight devices are particularly useful in emergency situations or in remote locations where access to traditional imaging equipment may be limited. Swiss healthcare providers are recognizing the value of portable imaging devices in improving patient outcomes and reducing healthcare costs.

Local special circumstances: Switzerland has a well-developed healthcare system that places a strong emphasis on quality and innovation. The country has a high density of healthcare facilities and a well-trained workforce, which creates a conducive environment for the adoption of advanced imaging technologies. Additionally, Switzerland is home to several leading medical device manufacturers, who are constantly introducing new and improved imaging devices to the market.

Underlying macroeconomic factors: Switzerland has a strong economy and high per capita income, which allows for significant investments in healthcare infrastructure and technology. The country also has a rapidly aging population, which is driving the demand for diagnostic imaging devices. As the elderly population increases, there is a greater need for early detection and accurate diagnosis of age-related conditions, leading to a higher demand for imaging devices. In conclusion, the Diagnostic Imaging Devices market in Switzerland is driven by customer preferences for advanced imaging technologies, such as digital imaging and portable devices. The country's well-developed healthcare system, emphasis on quality and innovation, and strong economy contribute to the growth and development of the market. The increasing demand for diagnostic imaging devices is also influenced by the aging population and the need for early detection and accurate diagnosis of age-related conditions.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.